In this interview, Dr. Susanne Back explains the growing role of antisense oligonucleotides (ASOs) in neuroscience drug discovery. She discusses their benefits, challenges in administration, in vivo ...
NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction . NMRA-215 demonstrated best-in-class weight loss of up to 26% in com ...
Boost Neuroscience is a “stealth” biotech company that has developed a proprietary synapse network platform based on the work of Nobel Laureate Dr. Thomas Südhof, M.D. Boost was spun out of Stanford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback